(Q30403251)

21 June 2017

1 reference

title

The influenza pandemic of 2009: lessons and implications (English)

1 reference

21 June 2017

0 references

pandemic preparedness

1 reference

1 reference

Paul Shapshak

1

1 reference

21 June 2017

Francesco Chiappelli

series ordinal

2

1 reference

21 June 2017

Charurut Somboonwit

series ordinal

3

1 reference

21 June 2017

John Sinnott

series ordinal

4

1 reference

21 June 2017

publication date

1 April 2011

1 reference

Molecular Diagnosis and Therapy

21 June 2017

published in

1 reference

21 June 2017

volume

15

1 reference

21 June 2017

issue

2

1 reference

21 June 2017

page(s)

63-81

1 reference

Influenza pandemics of the 20th century

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The influenza virus resource at the National Center for Biotechnology Information

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The influenza virus enigma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Emergence of a novel swine-origin influenza A (H1N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Critically ill patients with 2009 influenza A(H1N1) infection in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Use of cumulative incidence of novel influenza A/H1N1 in foreign travelers to estimate lower bounds on cumulative incidence in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The 2009 H1N1 Pandemic Influenza Virus: What Next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Influenza Vaccine — Safe, Effective, and Mistrusted

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Disease and destiny-mystery and mastery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Influenza-associated deaths in tropical Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Australia's winter with the 2009 pandemic influenza A (H1N1) virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Swine influenza virus: zoonotic potential and vaccination strategies for the control of avian and swine influenzas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

An overview of swine influenza.

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FBF03256397

21 January 2018

12 December 2020

Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009.

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The emergence of novel swine influenza viruses in North America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Novel swine influenza virus subtype H3N1, United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Isolation and characterization of novel H3N1 swine influenza viruses from pigs with respiratory diseases in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Genetic characterization of H3N2 influenza viruses isolated from pigs in North America, 1977-1999: evidence for wholly human and reassortant virus genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Evolution of swine H3N2 influenza viruses in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Characterization of avian H3N3 and H1N1 influenza A viruses isolated from pigs in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Continued evolution of H1N1 and H3N2 influenza viruses in pigs in Italy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Emergence and pandemic potential of swine-origin H1N1 influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The structural basis for cap binding by influenza virus polymerase subunit PB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Influenza virus mRNA translation revisited: is the eIF4E cap-binding factor required for viral mRNA translation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Influenza A virus PB1-F2: a small protein with a big punch.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The Contribution of the PB1-F2 Protein to the Fitness of Influenza A Viruses and its Recent Evolution in the 2009 Influenza A (H1N1) Pandemic Virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

An update on swine-origin influenza virus A/H1N1: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Evolutionary trends of A(H1N1) influenza virus hemagglutinin since 1918

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Recombination resulting in virulence shift in avian influenza outbreak, Chile

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Apoptosis and pathogenesis of avian influenza A (H5N1) virus in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Conserved amino acid markers from past influenza pandemic strains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The origins of pandemic influenza--lessons from the 1918 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Persistent host markers in pandemic and H5N1 influenza viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Genomic signatures of human versus avian influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Proteolytic activation of the 1918 influenza virus hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Origin and evolution of the 1918 "Spanish" influenza virus hemagglutinin gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Reassortment patterns in Swine influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Influenza virus: a master of metamorphosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Ecological and immunological determinants of influenza evolution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Influenza virus morphogenesis and budding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Positive Darwinian evolution in human influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The 1918 influenza pandemic: lessons for 2009 and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Origin and evolution of influenza virus hemagglutinin genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The 1918 influenza pandemic: insights for the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

21 January 2018

A history of influenza

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

1918 Influenza: the mother of all pandemics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The total influenza vaccine failure of 1947 revisited: major intrasubtypic antigenic change can explain failure of vaccine in a post-World War II epidemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Vaccine innovation: lessons from World War II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

1951 influenza epidemic, England and Wales, Canada, and the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Public health and medical responses to the 1957-58 influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Swine influenza a outbreak, Fort Dix, New Jersey, 1976

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Influenza A/USSR/77 (H1N1) on a university campus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Return of epidemic A1 (H1N1) influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Laboratory-based surveillance of influenza virus in the United States during the winter of 1977-1978. I. Periods of prevalence of H1N1 and H3N2 influenza A strains, their relative rates of isolation in different age groups, and detection of antigeni

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

H5N1 outbreaks and enzootic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Avian influenza A (H5N1) infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Avian influenza virus (H5N1): a threat to human health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Response to a monovalent 2009 influenza A (H1N1) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Efficacy of Whole‐Cell Killed Bacterial Vaccines in Preventing Pneumonia and Death during the 1918 Influenza Pandemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Studies of two kinds of virus particles which comprise influenza A2 virus strains. II. Reactivity with virus inhibitors in normal sera

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Independent variation in nature of hemagglutinin and neuraminidase antigens of influenza virus: distinctiveness of hemagglutinin antigen of Hong Kong-68 virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Epidemiology of influenza in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Swine-origin influenza virus in young age groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza virus hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

An overview of the epidemiology of avian influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

H5N1 Avian influenza: preventive and therapeutic strategies against a pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Preparing for the next influenza pandemic.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

SWINE INFLUENZA : I. EXPERIMENTAL TRANSMISSION AND PATHOLOGY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

SWINE INFLUENZA : III. FILTRATION EXPERIMENTS AND ETIOLOGY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

SWINE INFLUENZA : II. A HEMOPHILIC BACILLUS FROM THE RESPIRATORY TRACT OF INFECTED SWINE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

A COMPLEX VACCINE AGAINST INFLUENZA A VIRUS : QUANTITATIVE ANALYSIS OF THE ANTIBODY RESPONSE PRODUCED IN MAN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

A COMPLEX VACCINE EFFECTIVE AGAINST DIFFERENT STRAINS OF INFLUENZA VIRUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

THE SYNERGISM OF HUMAN INFLUENZA AND CANINE DISTEMPER VIRUSES IN FERRETS

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Concurrent infection with influenza virus and mumps virus or pneumonia virus of mice as bearing on the inhibition of virus multiplication by bacterial polysaccharides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Seasonal inactivated influenza virus vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Paradox of vaccination: is vaccination really effective against avian flu epidemics?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Reassortment between human A(H3N2) viruses is an important evolutionary mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Intracellular antibodies (intrabodies) and their therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Interfering vaccine (defective interfering influenza A virus) protects ferrets from influenza, and allows them to develop solid immunity to reinfection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Recent Patents on development of nucleic acid-based antiviral drugs against seasonal and pandemic influenza virus infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Neuraminidase inhibitors for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Genomic diversity of oseltamivir-resistant influenza virus A (H1N1), Luxembourg, 2007-08.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Peramivir (BCX-1812, RWJ-270201): potential new therapy for influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Containing pandemic influenza with antiviral agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Outbreak of antiviral drug-resistant influenza a in long-term care facility, Illinois, USA, 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Inhibition of influenza A virus reproduction by a ribozyme targeted against PB1 mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Small interfering RNA targeting m2 gene induces effective and long term inhibition of influenza A virus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Transmissibility of the 1918 pandemic influenza in Montreal and Winnipeg of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Flu database rocked by legal row.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Vaccine immunogenicity in injecting drug users: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

The evolution of human influenza A viruses from 1999 to 2006: a complete genome study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Homologous recombination evidence in human and swine influenza A viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

A primer on strategies for prevention and control of seasonal and pandemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Pandemic influenza. Straight from the pig's mouth: swine research with swine influenzas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

An outbreak of influenza in a residential drug-rehabilitation community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256397

Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008.

21 January 2018

1 reference

12 December 2020

RNA interference strategies as therapy for respiratory viral infections

1 reference

12 December 2020

Reverse genetics of influenza virus

1 reference

12 December 2020

Swine influenza virus: evolution mechanism and epidemic characterization--a review

1 reference

12 December 2020

An historical antecedent of modern guidelines for community pandemic influenza mitigation

1 reference

12 December 2020

Molecular basis for the generation in pigs of influenza A viruses with pandemic potential

1 reference

12 December 2020

Influenza A (H1N1) pandemic: preparedness and clinical management

1 reference

12 December 2020

Multinational impact of the 1968 Hong Kong influenza pandemic: evidence for a smoldering pandemic.

1 reference

12 December 2020

A study of excess mortality during influenza epidemics in the United States, 1968-1976

1 reference

12 December 2020

The influenza viruses.

1 reference

12 December 2020

Trials of aqueous killed influenza vaccine in Canada, 1968-69.

1 reference

12 December 2020

Chemotherapy and vaccination: a possible strategy for the control of highly virulent influenza virus

1 reference

12 December 2020

A comparison of the intradermal and subcutaneous routes of influenza vaccination with A/New Jersey/76 (swine flu) and A/Victoria/75: report of a study and review of the literature

1 reference

12 December 2020

The Use of a Vaccine in the recent Epidemic of Influenza.

1 reference

12 December 2020

Reassortment between amantadine-resistant and -sensitive H1N1 influenza A viruses generated an amantadine-sensitive virus during the 2007-2008 season

1 reference

12 December 2020

Nasal delivery of siRNA

1 reference

12 December 2020

Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease

1 reference

12 December 2020

Provision of influenza and pneumococcal vaccines to injection drug users at a syringe exchange

1 reference

12 December 2020

Experience with Vaccination Against Influenza in the Spring of 1947: A Preliminary Report

1 reference

12 December 2020

[Differential incorporation of genomic segments into the influenza A virus reassortants in mixed infection]

1 reference

12 December 2020

The chronicle of influenza epidemics

1 reference

12 December 2020

Effect of neuraminidase antibody on Hong Kong influenza

1 reference

12 December 2020

Broad-spectrum and virus-specific nucleic acid-based antivirals against influenza.

1 reference

12 December 2020

[Molecular analyses of human influenza viruses. Circulation of new variants since 1995/96]

1 reference

12 December 2020

Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine

1 reference

12 December 2020

Epidermal DNA vaccine for influenza is immunogenic in humans

1 reference

12 December 2020

Overview of the WHO Global Influenza Programme.

1 reference

12 December 2020

Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989

1 reference

12 December 2020

The syndrome of fatal influenza virus pneumonia.

1 reference

12 December 2020

Update on influenza activity--United States and worldwide, with recommendations for influenza vaccine composition for the 1988-89 season

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256397

1 reference

Dimensions Publication ID

21 June 2017

1028638516

0 references

1 reference